Financial results - NEFROLMED S.R.L.

Financial Summary - Nefrolmed S.r.l.
Unique identification code: 24773593
Registration number: J34/993/2008
Nace: 8610
Sales - Ron
2.750.659
Net Profit - Ron
47.437
Employees
56
Open Account
Company Nefrolmed S.r.l. with Fiscal Code 24773593 recorded a turnover of 2024 of 2.750.659, with a net profit of 47.437 and having an average number of employees of 56. The company operates in the field of Activităţi de asistenţă spitalicească having the NACE code 8610.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Nefrolmed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 2.643.056 2.416.271 2.489.609 2.512.467 2.435.376 2.727.816 2.256.695 2.560.859 2.666.454 2.750.659
Total Income - EUR 898.754 2.416.288 2.489.624 2.517.470 2.867.654 2.727.829 2.256.695 2.560.873 2.666.471 2.750.674
Total Expenses - EUR 826.319 2.389.163 2.465.817 2.572.309 2.932.234 2.599.877 2.124.835 2.527.123 2.637.475 2.693.810
Gross Profit/Loss - EUR 72.435 27.125 23.807 -54.839 -64.580 127.952 131.861 33.750 28.997 56.864
Net Profit/Loss - EUR 61.238 22.280 19.965 -54.839 -64.580 123.531 110.761 28.157 24.357 47.437
Employees 46 55 60 59 62 0 0 0 61 56
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 3.7%, from 2.666.454 euro in the year 2023, to 2.750.659 euro in 2024. The Net Profit increased by 23.216 euro, from 24.357 euro in 2023, to 47.437 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Nefrolmed S.r.l.

Rating financiar

Financial Rating -
NEFROLMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Nefrolmed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nefrolmed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Nefrolmed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nefrolmed S.r.l. - CUI 24773593

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 362.915 854.509 801.169 786.505 367.145 331.413 564.239 567.176 462.912 469.248
Current Assets 473.996 462.695 617.462 638.875 586.444 501.676 547.146 478.213 285.084 160.178
Inventories 198.112 216.231 337.706 357.497 525.623 317.266 470.153 146.144 80.178 73.092
Receivables 200.028 211.397 243.082 245.520 28.296 132.494 42.441 72.436 171.019 45.379
Cash 75.857 35.068 36.673 35.859 32.526 51.916 34.551 259.633 33.887 41.706
Shareholders Funds 194.633 214.928 20.009 -35.197 -99.096 26.314 136.492 59.237 52.484 99.628
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 642.278 1.102.277 1.398.622 1.460.577 1.052.685 806.776 974.892 986.152 695.512 529.798
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8610 - 8610"
CAEN Financial Year 8610
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 160.178 euro in 2024 which includes Inventories of 73.092 euro, Receivables of 45.379 euro and cash availability of 41.706 euro.
The company's Equity was valued at 99.628 euro, while total Liabilities amounted to 529.798 euro. Equity increased by 47.438 euro, from 52.484 euro in 2023, to 99.628 in 2024.

Risk Reports Prices

Reviews - Nefrolmed S.r.l.

Comments - Nefrolmed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.